Sign Out
Pregnancy: There is limited experience with the use of Vaxneuvance in pregnant women.
Animal studies do not indicate direct or indirect harmful effects with respect to pregnancy, embryo/foetal development, parturition or post-natal development (see Pharmacology: Toxicology: Preclinical safety data under Actions).
Administration of Vaxneuvance in pregnancy should only be considered when the potential benefits outweigh any potential risks for the mother and the foetus.
Breast-feeding: It is unknown whether Vaxneuvance is excreted in human milk.
Fertility: No human data on the effect of Vaxneuvance on fertility are available. Animal studies in female rats do not indicate harmful effects (see Pharmacology: Toxicology: Preclinical safety data under Actions).
